Search Results1-12 of  12

  • HIDA TOYOAKI ID: 9000016267032

    2nd Department of Internal Medicine, Nagoya City University Medical School (1990 from CiNii)

    Articles in CiNii:1

    • Establishment of Small Cell Lung Cancer Cell Lines and Study of Antigenic Phenotype, Chemosensitivity and Radiosensitivity (1990)
  • HIDA Toyoaki ID: 9000018719305

    Aichi Cancer Center Hospital (2011 from CiNii)

    Articles in CiNii:1

    • Phase I study of intravenous ASA404 (vadimezan) administered in combination with paclitaxel and carboplatin in Japanese patients with non-small cell lung cancer (2011)
  • Hida Toyoaki ID: 9000004433919

    Articles in CiNii:127

    • 肺癌におけるcyclooxygenase-2過剰発現の臨床的意義--分子標的としてのcyclooxygenase-2 (〔2001年12月〕第1土曜特集 肺癌の分子生物学) -- (新しい予後因子と薬剤耐性規定因子) (2001)
    • COX-2を標的にした肺がんの治療 (2004)
    • 悪性胸膜中皮腫に対する化学療法 (特集:中皮腫トピックス) (2006)
  • Hida Toyoaki ID: 9000021608999

    Department of Thoracic Oncology, Aichi Cancer Center Hospital (2009 from CiNii)

    Articles in CiNii:1

    • Clinical Study of LY231514 (Pemetrexed) in Combination with Cisplatin in Patients with Malignant Pleural Mesothelioma to Determine Safety (2009)
  • Hida Toyoaki ID: 9000021947568

    Department of Thoracic Oncology, Aichi Cancer Center Hospital (2009 from CiNii)

    Articles in CiNii:1

    • Soluble Mesothelin-related Peptides (SMRP) as a Biomarker for Malignant Pleural Mesothelioma (2009)
  • Hida Toyoaki ID: 9000021947583

    Department of Thoracic Oncology, Aichi Cancer Center Hospital (2009 from CiNii)

    Articles in CiNii:1

    • Chemosensitivity in Malignant Mesothelioma; Future Strategy (2009)
  • Hida Toyoaki ID: 9000253601200

    Internal Medicine, Enshu General Hospital (1984 from CiNii)

    Articles in CiNii:1

    • Diagnosis of the causes of the pleural effusion by biochemical parameters. (1984)
  • Hida Toyoaki ID: 9000254627433

    Department of Respiratory Medicine, Aichi Cancer Center (2002 from CiNii)

    Articles in CiNii:1

    • TTF-1 Immunostaining in the Diagnosis of Gastric Metastasis From Lung Adenocarcinoma. (2002)
  • Hida Toyoaki ID: 9000283425031

    Department of Thoracic Oncology, Aichi Cancer Center (2014 from CiNii)

    Articles in CiNii:1

    • Phase I/II Study of Alectinib (CH5424802/RO5424802) in Patients with ALK-rearranged Non-small Cell Lung Cancer (NSCLC): Updated Results from the AF-001JP Trial (2014)
  • Hida Toyoaki ID: 9000305638996

    Department of Thoracic Oncology, Aichi Cancer Center Hospital (2015 from CiNii)

    Articles in CiNii:1

    • A Case of Recurrent Thymic Atypical Carcinoid with Pleural and Peritoneal Dissemination Six Years After Thymectomy (2015)
  • Hida Toyoaki ID: 9000397828299

    Articles in CiNii:1

    • Osimertinib in Japanese patients with EGFR T790M mutation-positive advanced non-small-cell lung cancer: AURA3 trial (2018)
  • Hida Toyoaki ID: 9000398839527

    Articles in CiNii:1

    • Diagnosis by Volatile Organic Compounds in Exhaled Breath from Lung Cancer Patients Using Support Vector Machine Algorithm (2017)
Page Top